Compugen Ltd. (CGEN)
Compugen Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Compugen Ltd. (CGEN) is a Biotechnology company based in IL with a market capitalization of $235.4M. Revenue grew 161.1% year-over-year and the company generated $31.3M in free cash flow. This page tracks CGEN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
IL · 74 employees · IPO Aug 11, 2000
Valuation
Valuation & price
$2.65as of May 26, 2026· -14.4% vs 52w high
7.0
P/E ratio
Latest-FY diluted EPS
2.29
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$235.4M
Market cap
161.1%
Revenue growth (YoY)
87.3%
Gross margin
$31.3M
Free cash flow (USD)
-$142.7M
Net debt
Net cash position
4.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last reported: May 18, 2026 (EPS $-0.08)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 13, 2026Filing
Insider Sell $5K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $4.7K
- Annual reportMay 18, 2026Filing
Annual Report Filed
- Insider sellApr 27, 2026Filing
Insider Sell $16K · 10b5-1 PlanOphir Eran · Director, President and CEO · $16K
- Insider sellApr 27, 2026Filing
Insider Sell $6K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $6.4K
- Insider sellApr 15, 2026Filing
Insider Sell $8K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $8K
- Insider sellApr 15, 2026Filing
Insider Sell $6K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $5.6K
- Insider sellApr 15, 2026Filing
Insider Sell $15K · 10b5-1 PlanOphir Eran · Director, President and CEO · $14.5K
- Insider sellApr 13, 2026Filing
Insider Sell $8K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $8K
- Insider sellApr 9, 2026Filing
Insider Sell $19K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $18.8K
- Insider sellApr 3, 2026Filing
Insider Sell $12K · 10b5-1 PlanOphir Eran · Director, President and CEO · $12.4K
Questions
Frequently asked questions
What is Compugen Ltd.'s market cap?
Compugen Ltd. (CGEN) has a market capitalization of $235.4M.
What is CGEN's P/E ratio?
CGEN trades at a price-to-earnings ratio of 7.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is CGEN's price-to-book (P/B) ratio?
CGEN trades at 2.29 times book value per share.
When did Compugen Ltd. last report earnings?
CGEN last reported earnings on May 18, 2026; the next date is not yet scheduled.
Are insiders buying CGEN stock?
SEC Form 4 filings show no open-market insider buys at Compugen Ltd. in the last 90 days (3 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.